The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT

Not Applicable

Completed

• Conditions: HIV Infections; Cytopenias

• Registration Number: NCT00002302
• Lead Sponsor: Ortho Pharmaceuticals

Brief Summary

To determine the safety and efficacy of erythropoietin administered subcutaneously to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy. Efficacy will be assessed by correction of anemia and decrease in transfusion requirements.

Detailed Description

Not available

Study Timeline

• Status Verified: 1989-12
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

AIDS Research Consortium of Atlanta; 🇺🇸 Atlanta, Georgia, United States

Ortho Pharmaceutical Corp; 🇺🇸 Raritan, New Jersey, United States